FDA Approved: OTEZLA — Supplemental Application (Amgen, Inc)

View source ↗

Summary

The FDA approved a supplemental application for OTEZLA (apremilast) from Amgen, potentially expanding or updating its label.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis
• Psoriatic Arthritis

Drugs mentioned

• OTEZLA (apremilast)

Snippet

SUPPL AP for OTEZLA (APREMILAST)